Retrospective analysis shows 90-day mortality of 8.5% in patients ≥ 70 with renal cell carcinoma, indicating heightened risk for those ≥ 80.
Abstract Purpose : Inferior vena cava (IVC) thrombus is a severe presentation of renal cell carcinoma (RCC), traditionally treated with radical nephrectomy and thrombus extraction. However, the benefit-risk balance in elderly patients remains unclear due to limited data. This study aimed to assess surgical outcomes—particularly 90-day mortality—in patients aged ≥ 70 year and identify risk factors for postoperative mortality. Methods: We retrospectively analyzed data from the prospective French UroCCR national cohort (2007–2023), including 298 patients with RCC with IVC thrombus who underwent surgery in 13 expert centers. Patients were stratified into ≥ 70 vs. <70 year. The primary endpoint was 90-day mortality. Secondary outcomes included overall survival (OS), disease-specific survival (DSS), and predictors of postoperative 90-d death. Statistical analyses included univariate and multivariate logistic regression adjusted for sex, ASA score, and eGFR. Results: Among the 117 elderly patients, 90-d mortality was 8.5% vs. 5.5% in younger patients (p = 0.33). In those aged ≥ 80 year (n = 32), 90-d mortality reached 19% (p = 0.02). Impaired eGFR < 45 mL/min was the only significant predictor of postoperative death (OR 3.9, p = 0.04). Long-term DSS was comparable between age groups. Study limitations include its retrospective design and inclusion of only surgical candidates. Conclusions: Radical nephrectomy with thrombus extraction yields acceptable outcomes in patients aged ≥ 70 year, though ≥ 80 year face higher perioperative risk. Careful selection—including renal function evaluation—is crucial. DSS equivalence suggests age alone should not contraindicate surgery.
No takes yet. Share an insight, caveat, or question.
Brek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: